Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Sten Frelles who wrote (771)	3/14/2000 4:37:00 PM
From: Timoteo	Read Replies (1) \| Respond to of 1298

Sten, I think CEGE got swept down with HGSI and the other gene mapping stocks after the Clinton-Blair news announcement. The street always overreacts to any news good or bad and the negative sentiment was enough of a push to send it down. I think the stock could go as low as 23, but I think we're more likely to see 35 first. Stocks like this can turn on a dime so I just try not to worry. A good example is to look at the chart of KANA. Lots of broken hearted sellers. I actually bought back some calls I sold and bought some April 35s outright. CEGE is my biggest position but I'm not sweating yet. Best, Timoteo